Recent advances in the diagnosis, prognosis and classification of childhood solid tumours

British Medical Bulletin

Volumn 52, Issue 4, 1996, Pages 724-741

  Ramani, Pramila ^a   Shipley, Janet ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GENETICS; CHILDHOOD CANCER; CLINICAL PRACTICE; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EWING SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GERM CELL TUMOR; HETEROZYGOSITY LOSS; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHABDOMYOSARCOMA; SOLID TUMOR;

EID: 0030444833     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011579     Document Type: Review

References (44)

1. Brown R, Chirala R. Utility of micro-wave antigen retrieval in diagnostic immunohistochemistry. Modern Pathol 1995; 8: 515-20
2. Ramani P, Dewchand H. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma. J Pathol 1995; 175: 13-22
3. McManus AP, Gusterson BA, Pinkerton CR, Shipley JM. The molecular pathology of the small round cell tumours-relevance to diagnosis, prognosis and classification. J Pathol 1996; 178: 116-21
4. Brodeur GM, Pritchard J, Berthold F et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 1993; 11: 1466-77
5. Takeda O, Homma C, Maseki N et al. There may be two tumour suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom Cancer 1994; 10: 30-9
6. Schleiermacher G, Peter M, Michon J. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chrom Cancer 1994; 10: 275-81
7. Kogner P, Barbany G, Bjork O et al. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors. Prog Clin Biol Res 1994; 385: 137-45
8. Nakagawara A, Arima NM, Scavarda NJ et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993; 328: 847-54
9. Dominici C, Nicotra M, Digiesi G et al. Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma. Eur J Cancer 1995; 31A: 444-6
10. Hoehner JC, Olsen L, Sandstedt B, Kaplan DR, Pahlman S. Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am J Pathol 1995; 147: 102-13
11. Terpe H, Christiansen H, Berthold F et al. Absence of CD44 standard in human neuroblastoma correlates with histological dedifferentiation, MYCN amplification and reduced survival probability. Cell Death Different 1994; 1: 123-8
12. Combaret V, Lasset C, Frappaz D et al. Evaluation of CD44 prognostic value in neuroblastoma: Comparison with the other prognostic factors. Eur J Cancer 1995; 31A: 545-9
13. Christiansen H, Sahin K, Berthold F et al. Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma. Eur J Cancer 1995; 31A: 541-4
14. Castle V, Heidelberger KP, Bromberg J et al. Expression of apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavourable histology and N-MYC amplification. Am J Pathol 1991; 143: 1543-50
15. Ramani P, Lu Q-L. Expression of bcl-2 gene product in neuroblastoma. J Pathol 1994; 172: 273-8
16. Thomas J, Nijjar J, Turley H, Micklem K, Garter K. NB84: a new monoclonal antibody for the recognition of neuroblastoma in routinely processed material. J Pathol 1991; 163: 69-75
17. Newton W, Gehan E, Webber B et al. Classification of rhabdomyosarcoma and related sarcomas. Cancer 1995; 76: 1073-85
18. Clark J, Rocques PJ, Braun T et al. Expression of members of the myf gene family in human rhabdomyosarcomas. Br J Cancer 1991; 64: 1049-52
19. Parham DM, Dias P, Kelly DR, Rutledge JC, Houghton P. Desmin positivity in primitive neuroectodermal tumors of childhood. Am J Surg Pathol 1992; 16: 483-92
20. Barr FG, Chatten J, D'Cruz CM et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcoma. JAMA 1995; 273: 553-7
21. McManus AP, O'Reilly MJ, Pritchard-Jones K et al. Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) - a diagnostic tool in minimally invasive biopsies. J Pathol 1996; 178: 410-14
22. Barr FG, Nauta LE, Davis RJ et al. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mol Genet 1996; 5: 15-21
23. Weber-Hall S, McManus A, Anderson J et al. Novel formation of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma. Genes Chrom Cancer 1996; In press
24. Douglass EC, Shapiro DN, Valentine M, Rowe ST. Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 1993; 21: 83-7
25. Driman D, Thorner PS, Greenberg ML, Chilton-MacNeill S, Squires J. MYCN gene amplification in rhabdomyosarcoma. Cancer 1994; 73: 2231-7
26. Wijnaendts LCD, Linden JC, Diest PJ et al. Prognostic importance of DNA flow cytometric variables in rhabdomyosarcoma. J Clin Pathol 1993; 46: 948-52
27. Pappo AS, Crist WM, Kuttesch J et al. Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 1993; 11: 1901-5
28. Dehner LP. Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 1993; 17: 1-13
29. Kaneko Y, Yoshida K, Handa M et al. Fusion of an ETS-family gene, E1AF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chrom Cancer 1996; 15: 115-21
30. McManus AP, Gusterson BA, Pinkerton CR, Shipley JM. Diagnosis of Ewing's sarcoma and related tumours by fluorescence in situ hybridisation detection of chromosome 22q12 translocations on tumour touch imprints. J Pathol 1995; 176: 137-42
31. Stevenson A, Chatten J, Bertoni F, Miettenen M. CD99 (p30/32 MIC2) neuroectodermal/ Ewing's sarcoma antigen as an immunohistochemical marker. Review of more than 600 tumours and literature experience. Appl Immunohistochem 1994; 2: 231-40
32. Ramani P, Rampling D, Link M. Immunocytochemical study of 12E7 in small-round cell tumours of childhood: an assessment of its sensitivity and specificity. Histopathology 1993; 23: 557-61
33. Sorenson PHB, Shimada H, Liu XF et al. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Cancer Res 1995; 55: 1385-92
34. Gerald W, Miller H, Battifora H et al. Intra-abdominal desmoplastic small round-cell tumour. Report of 19 cases of a distinctive type of high grade polyphenotypic malignancy affecting young individuals. Am J Pathol 1991; 15: 499-513
35. Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumour. Cancer Res 1994; 54: 2837-40
36. Biegel JA, Rorke LB, Janss AJ, Sutton LN, Parmiter AH. Isochromosome 17q demonstration by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system. Genes Chrom Cancer 1995; 14: 85-96
37. Willert JR, Daneshvar L, Sheffield VR, Cogan PH. Deletion of chromosome arm 17p DNA-sequences in pediatric high-grade and juvenile pilocytic astrocytomas. Genes Chrom Cancer 1995; 12: 165-72
38. Pomeroy SL. The p53 tumor suppressor gene and pediatric brain tumors. Curr Opin Pediatr 1994; 6: 632-5
39. Kimmel DW, O'Fallon JR, Scheithauer BW et al. Prognostic value of cytogenetic analysis in human cerebral astrocytomas. Ann Neurol 1992; 31: 534-42
40. Rodriguez E, Houldsworth J, Reuter VE et al. Molecular cytogenetic analysis of i(12p) negative human male germ cell tumors. Genes Chrom Cancer 1993; 8: 230-6
41. Perlman EJ, Valentine MB, Griffin CA, Look AT. Deletion of 1p36 in childhood endodermal sinus tumors by two-color fluorescence in situ hybridization: a pediatric oncology group study. Genes Chrom Cancer 1996; 16: 15-20
42. Rubie H, Gladieff L, Robert A, et al. Childhood anaplastic large-cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases. Med Pediatr Oncol 1994; 22: 155-61
43. Morris SW, Kistein MK, Valentine MB et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281-4
44. Shiota M, Nakamura S, Ichinohasama R et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995; 86: 1954-60